SCIESCOPUSQ1
Expert Opinion on Drug Discovery
TAYLOR & FRANCIS LTD, United Kingdom
Expert Opinion on Drug Discovery is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1746-0441, eISSN 1746-045X. Indexed in SCIE, SCOPUS. Metrics: JIF 4.9, CiteScore 10.6, SJR 1.195, SNIP 1.07. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 2,281 papers from this journal.
CiteScore
10.60
Zitationsmetrik in Scopus
SJR
1.195
SCImago-Rang
SNIP
1.07
Source-Normalized Impact
Prozentrang
-
JIF-Perzentilrang
Zeitschriftenprofil
- ISSN
- 1746-0441
- eISSN
- 1746-045X
- Abkürzung
- EXPERT OPIN DRUG DIS
- Verlag
- TAYLOR & FRANCIS LTD
- Land
- United Kingdom
Web of Science-Kategorien
SCIEPHARMACOLOGY & PHARMACY
Scopus-ASJC-Kategorien
3002 Drug Discovery
Schlüsselwörter
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.
2026
- Advances in methicillin-resistant Staphylococcus aureus drug discovery: developments and challenges
2026 · 1 citations
- The impact of free radicals on opioid receptors in tissue injury and inflammation: implications for drug design
2026
- Epigenetic reactivation in Friedreich's ataxia from Benzamides to gene‑Targeted chimeras.
2026
- In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives.
2026
Most cited papers
- The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
2015 · 4,652 citations
- Lipophilicity in drug discovery
2010 · 758 citations
- The influence of lipophilicity in drug discovery and design
2012 · 747 citations
- Virtual Screening with AutoDock: Theory and Practice
2010 · 638 citations
- Molecular dynamics simulations and novel drug discovery
2018 · 427 citations